Better Engineered
Solutions
Cell Therapy
Whether you are looking to commercialise the next autologous or allogeneic cell therapy, CAR-T, or stem, our experienced Process Architects and Engineers will create a best in class design, fit for ‘your process’ development and manufacturing facility enabling you to rapidly bring your cell therapy product to the patients that urgently need these life-changing therapies. Contact us to discuss how we can support your next cell therapy project.
-
bluebird bio, Clinical Manufacturing Facility
DPS was retained as the design partner to perform the Concept Design for a cGMP clinical manufacturing facility/Pilot Plant for a CAR-T cell therapy product.
-
BMS, Cell Therapy Facility
The CAR-T Cell Therapy Facility (CTF) project will be a multi-product facility consisting of 4 production and 2 filling suites with supporting utilities labs, offices and logistic facilities with an overall area of ~20,000m².
-
ElevateBio, Clinical Manufacturing Facility
DPS was selected to provide professional architectural and engineering services to develop a full design package for ElevateBio’s Massachusetts-based clinical manufacturing facility.
-
Lonza Biologics, Multi-product Cell Therapy Manufacturing Suite
Lonza Biologics contracted DPS Group to retrofit an existing manufacturing area to convert the space to a multi-product cell therapy manufacturing suite at its Portsmouth, NH facility.
-
Mustang Bio, Cell Processing Facility
DPS Group executed full BOD, Detailed Design and Construction Administration for Mustang Bio’s Cell Processing Facility in Worcester, MA.
-
Novartis, Project Next
DPS were engaged to provide the facilities detailed design for Phase 1 of a CAR-T phased manufacturing capacity for Novartis in Stein.
-
Replimune, Clinical Manufacturing Facility
DPS was hired to provide engineering and design services for a new cGMP manufacturing facility having completed the process definition and test fit phases.
-
Sangamo Therapeutics, CAR-Treg Clinical Facility
DPS was engaged to develop a feasibility study to assess the opportunity to retrofit an existing building with a CAR-Treg cell therapy clinical manufacturing facility.
-
Semma Therapeutics, R&D and Clinical Manufacturing Facility
DPS completed the MEP Design for the space to accommodate R&D labs and support areas in Semma’s new Cambridge, MA location.
-
Vertex, Gene / Cell Therapy Manufacturing Facility
DPS was engaged to assist Vertex in determining feasibility to build a multi-product, flexible Gene / Cell Therapy Manufacturing facility in Massachusetts.
